| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
Update of the drug resistance mutations in HIV-1: Spring 2008.
|
2008
|
3.66
|
|
2
|
Update of the drug resistance mutations in HIV-1: December 2009.
|
2009
|
3.52
|
|
3
|
Update of the drug resistance mutations in HIV-1: Fall 2006.
|
2006
|
3.06
|
|
4
|
Update of the Drug Resistance Mutations in HIV-1.
|
2008
|
2.91
|
|
5
|
Update of the drug resistance mutations in HIV-1: December 2010.
|
2010
|
2.91
|
|
6
|
Update of the drug resistance mutations in HIV-1: 2007.
|
2007
|
2.79
|
|
7
|
Antiretroviral adherence interventions: a review of current literature and ongoing studies.
|
2004
|
2.64
|
|
8
|
Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.
|
2009
|
2.30
|
|
9
|
A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth.
|
2009
|
2.24
|
|
10
|
Elite control of HIV Infection: implications for vaccines and treatment.
|
2007
|
2.16
|
|
11
|
Neurologic complications of HIV disease and their treatment.
|
2010
|
2.14
|
|
12
|
Improving engagement in HIV care: what can we do?
|
2008
|
2.05
|
|
13
|
Update of the drug resistance mutations in HIV-1: Fall 2005.
|
2005
|
2.04
|
|
14
|
HIV disease progression: immune activation, microbes, and a leaky gut.
|
2007
|
1.87
|
|
15
|
HIV and sexually transmitted diseases: lethal synergy.
|
2004
|
1.84
|
|
16
|
Update of the Drug Resistance Mutations in HIV-1: 2005.
|
2005
|
1.83
|
|
17
|
Drug resistance mutations in HIV-1.
|
2003
|
1.72
|
|
18
|
Secrets and safety in the age of AIDS: does HIV disclosure lead to safer sex?
|
2004
|
1.71
|
|
19
|
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.
|
2006
|
1.65
|
|
20
|
Update of the drug resistance mutations in HIV-1: 2004.
|
2004
|
1.62
|
|
21
|
Structured treatment interruptions--new findings.
|
2006
|
1.41
|
|
22
|
Drug resistance mutations in HIV-1.
|
2004
|
1.37
|
|
23
|
HIV-associated neurocognitive disease continues in the antiretroviral era.
|
2008
|
1.35
|
|
24
|
HIV in adolescents and young adults: half of all new infections in the United States.
|
2005
|
1.33
|
|
25
|
Use of club drugs by HIV-seropositive and HIV-seronegative gay and bisexual men.
|
2003
|
1.32
|
|
26
|
Renal dysfunction and tenofovir toxicity in HIV-infected patients.
|
2008
|
1.30
|
|
27
|
Review of treatment studies of depression in HIV.
|
2006
|
1.30
|
|
28
|
Oral manifestations of HIV disease.
|
2005
|
1.25
|
|
29
|
Update on cardiovascular complications in HIV infection.
|
2009
|
1.25
|
|
30
|
Dyslipidemia and its Treatment in HIV Infection.
|
2010
|
1.24
|
|
31
|
Non--AIDS-defining malignancies in HIV.
|
2008
|
1.22
|
|
32
|
Prioritizing primary care in HIV: comorbidity, toxicity, and demography.
|
2007
|
1.17
|
|
33
|
Sex differences in adverse reactions to antiretroviral drugs.
|
2003
|
1.17
|
|
34
|
Cost-effectiveness of HIV interventions: from cohort studies and clinical trials to policy.
|
2009
|
1.15
|
|
35
|
Drug Resistance Mutations in HIV-1.
|
2003
|
1.13
|
|
36
|
Neurologic complications of HIV disease and their treatment.
|
2009
|
1.13
|
|
37
|
Methamphetamine use in urban gay and bisexual populations.
|
2006
|
1.11
|
|
38
|
Dermatologic manifestations of HIV infection.
|
2005
|
1.08
|
|
39
|
Advances in antiretroviral therapy.
|
2007
|
1.05
|
|
40
|
Substance abuse and HIV infection.
|
2003
|
1.04
|
|
41
|
Dermatologic manifestations of HIV in Africa.
|
2010
|
1.03
|
|
42
|
Human papillomavirus infection in HIV-infected persons.
|
2007
|
1.02
|
|
43
|
Pathogenesis of HIV infection: total CD4+ T-cell pool, immune activation, and inflammation.
|
2010
|
1.01
|
|
44
|
Antiretroviral drug resistance and resistance testing.
|
2005
|
1.00
|
|
45
|
Moving beyond interferon alfa: investigational drugs for hepatitis C virus infection.
|
2010
|
0.99
|
|
46
|
Reproduction decision making for couples affected by HIV: a review of the literature.
|
2004
|
0.98
|
|
47
|
Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
|
2005
|
0.97
|
|
48
|
What do we need to do to cure HIV infection.
|
2010
|
0.97
|
|
49
|
Tuberculosis and HIV in the Caribbean: approaches to diagnosis, treatment, and prophylaxis.
|
2005
|
0.97
|
|
50
|
Current concepts in antiretroviral therapy failure.
|
2006
|
0.93
|